Tirzepatide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 84643-102
  • Package NDC 84643-102-30
  • Package NDC 84643-102-31
  • Package NDC 84643-102-32
  • Package NDC 84643-102-33
  • Package NDC 84643-102-34
  • Package NDC 84643-102-35
  • Package NDC 84643-102-36
  • Package NDC 84643-102-37
  • Package NDC 84643-102-38
  • Package NDC 84643-102-39
  • Package NDC 84643-102-40
  • Package NDC 84643-102-41
  • SPL ID 4cb867f6-c3d5-9061-e063-6294a90a9f85

What the source publishes

Labeler
Zhejiang Tasln Biopharma Co., Ltd.
Active ingredients
Tirzepatide
Form
POWDER
Administrative status
present-in-source-snapshot
Marketing status
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Product type
BULK INGREDIENT

Names this record is found by

Complete source data
us:fda:ndc:84643-102_4cb867f6-c3d5-9061-e063-6294a90a9f85
{
  "name": "Tirzepatide",
  "splId": "4cb867f6-c3d5-9061-e063-6294a90a9f85",
  "labels": [],
  "routes": [],
  "labeler": "Zhejiang Tasln Biopharma Co., Ltd.",
  "finished": false,
  "packaging": [
    {
      "description": "1 g in 1 CONTAINER (84643-102-30)",
      "package_ndc": "84643-102-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "2 g in 1 CONTAINER (84643-102-31)",
      "package_ndc": "84643-102-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "5 g in 1 CONTAINER (84643-102-32)",
      "package_ndc": "84643-102-32",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "10 g in 1 CONTAINER (84643-102-33)",
      "package_ndc": "84643-102-33",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "20 g in 1 CONTAINER (84643-102-34)",
      "package_ndc": "84643-102-34",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "50 g in 1 CONTAINER (84643-102-35)",
      "package_ndc": "84643-102-35",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "100 g in 1 CONTAINER (84643-102-36)",
      "package_ndc": "84643-102-36",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "200 g in 1 CONTAINER (84643-102-37)",
      "package_ndc": "84643-102-37",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "500 g in 1 CONTAINER (84643-102-38)",
      "package_ndc": "84643-102-38",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "1000 g in 1 CONTAINER (84643-102-39)",
      "package_ndc": "84643-102-39",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "2000 g in 1 CONTAINER (84643-102-40)",
      "package_ndc": "84643-102-40",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    },
    {
      "description": "5000 g in 1 CONTAINER (84643-102-41)",
      "package_ndc": "84643-102-41",
      "identifierStatus": "well-formed",
      "marketing_start_date": "11-MAR-26"
    }
  ],
  "productId": "84643-102_4cb867f6-c3d5-9061-e063-6294a90a9f85",
  "useDomain": "unknown",
  "dosageForm": "POWDER",
  "productNdc": "84643-102",
  "deaSchedule": null,
  "genericName": "Tirzepatide",
  "productType": "BULK INGREDIENT",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TIRZEPATIDE",
      "strength": "1 g/g"
    }
  ],
  "applicationNumber": null,
  "marketingCategory": "BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260311",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {},
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:84643-102_4cb867f6-c3d5-9061-e063-6294a90a9f85"